Trials & Filings
Related Searches:
Filter by:
1 - 15 of 604 results
February 22, 2013
Kadcyla approved for HER2-positive metastatic breast cancer
Read More »
October 22, 2012
EMA approves commercial production for Actavis drug
Read More »
September 24, 2012
Contractor error associated with bavituximab trial
Read More »
August 24, 2012
Takes $1.8 billion write-off after safety issues arise in Phase II
Read More »
August 7, 2012
Discontinues development of IV formulation
Read More »
July 5, 2012
Coating Place to supply patent-protected API
Read More »
May 29, 2012
Isis earns $25 million milestone payment for HoFH
Read More »
May 7, 2012
Trial shows lack of clinically meaningful efficacy
Read More »
May 3, 2012
Fill/finish line in Ireland to double Myozyme, Lumizyme capacity
Read More »
April 5, 2012
Will initiate statin trial for Zhejian Hisun
Read More »
January 27, 2012
FDA says Formatech was not in compliance with cGMP requirements
Read More »
January 9, 2012
Trial restarts with replacement material
Read More »
November 30, 2011
Cara uses Peptelligence to advance CR845 formulation
Read More »
September 26, 2011
InSite Vision Selects CRO for DOUBle Trial
Read More »
August 2, 2011
Migraine med NDA filing triggers collaboration payment
Read More »
1 - 15 of 604 results
